Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2017

02.05.2017 | Gastrointestinal Oncology

Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma

verfasst von: Fabio Bagante, MD, Gaya Spolverato, MD, Matthew Weiss, MD, Sorin Alexandrescu, MD, Hugo P. Marques, MD, Luca Aldrighetti, MD, Shishir K. Maithel, MD, Carlo Pulitano, MD, Todd W. Bauer, MD, Feng Shen, MD, George A. Poultsides, MD, Oliver Soubrane, MD, Guillaume Martel, MD, B. Groot Koerkamp, MD, Alfredo Guglielmi, MD, Endo Itaru, MD, Timothy M. Pawlik, MD, MPH, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The influence of morphological status on the long-term outcome of patients undergoing liver resection for intrahepatic cholangiocarcinoma (ICC) is poorly defined. We sought to study the impact of morphological status on overall survival (OS) of patients undergoing curative-intent resection for ICC.

Methods

A total of 1083 patients who underwent liver resection for ICC between 1990 and 2015 were identified. Data on clinicopathological characteristics, operative details, and morphological status were recorded and analyzed. A propensity score-matched analysis was performed to reduce confounding biases.

Results

Among 1083 patients, 941(86.9%) had a mass-forming (MF) or intraductal-growth (IG) type, while 142 (13.1%) had a periductal-infiltrating (PI) or MF with PI components (MF + PI) ICC. Patients with an MF/IG ICC had a 5-year OS of 41.8% (95% confidence interval [CI] 37.7–45.9) compared with 25.5% (95% CI 17.3–34.4) for patients with a PI/MF + PI (p < 0.001). Morphological type was found to be an independent predictor of OS as patients with a PI/MF + PI ICC had a higher hazard of death (hazard ratio [HR] 1.42, 95% CI 1.11–1.82; p = 0.006) compared with patients who had an MF/IG ICC. Compared with T1a–T1b–T2 MF/IG tumors, T1a–T1b–T2 PI/MF + PI and T3–T4 PI/MF + PI tumors were associated with an increased risk of death (HR 1.47 vs. 3.59). Conversely, patients with T3–T4 MF/IG tumors had a similar risk of death compared with T1a–T1b–T2 MF/IG patients (p = 0.95).

Conclusion

Among patients undergoing curative-intent resection of ICC, morphological status was a predictor of long-term outcome. Patients with PI or MF + PI ICC had an approximately 45% increased risk of death long-term compared with patients who had an MF or IG ICC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Liver Cancer Study Group of Japan. Intrahepatic cholangiocarcinoma macroscopic typing. In: Okamoto E (ed). Classification of primary liver cancer. Tokyo, Japan, Kanehara; 1997. pp 6–7. Liver Cancer Study Group of Japan. Intrahepatic cholangiocarcinoma macroscopic typing. In: Okamoto E (ed). Classification of primary liver cancer. Tokyo, Japan, Kanehara; 1997. pp 6–7.
2.
Zurück zum Zitat Dodson RM, Weiss MJ, Cosgrove D, et al. Intrahepatic cholangiocarcinoma: management options and emerging therapies. Journal of the American College of Surgeons. 2013;217(4):736–50.CrossRefPubMed Dodson RM, Weiss MJ, Cosgrove D, et al. Intrahepatic cholangiocarcinoma: management options and emerging therapies. Journal of the American College of Surgeons. 2013;217(4):736–50.CrossRefPubMed
3.
Zurück zum Zitat Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. Journal of Surgical Oncology. 2014;110(2):163–70.CrossRefPubMed Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. Journal of Surgical Oncology. 2014;110(2):163–70.CrossRefPubMed
4.
Zurück zum Zitat de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of Clinical Oncology. 2011;29(23):3140–45.CrossRefPubMed de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of Clinical Oncology. 2011;29(23):3140–45.CrossRefPubMed
5.
Zurück zum Zitat Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153(6):811–18.CrossRefPubMedPubMedCentral Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153(6):811–18.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surgery. 2014;149(6):565–74.CrossRefPubMed Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surgery. 2014;149(6):565–74.CrossRefPubMed
7.
Zurück zum Zitat Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Annals of Surgical Oncology. 2009;16(1):14–22.CrossRefPubMed Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Annals of Surgical Oncology. 2009;16(1):14–22.CrossRefPubMed
8.
Zurück zum Zitat Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology. 2010;26(3):269–73.CrossRefPubMed Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology. 2010;26(3):269–73.CrossRefPubMed
9.
Zurück zum Zitat Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2014;18(7):1284–91.CrossRefPubMed Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2014;18(7):1284–91.CrossRefPubMed
10.
Zurück zum Zitat Spolverato G, Kim Y, Ejaz A, et al. Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients. JAMA Surgery. 2015;150(6):538–45.CrossRefPubMed Spolverato G, Kim Y, Ejaz A, et al. Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients. JAMA Surgery. 2015;150(6):538–45.CrossRefPubMed
11.
Zurück zum Zitat Spolverato G, Vitale A, Cucchetti A, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer. 2015;121(22):3998–4006.CrossRefPubMed Spolverato G, Vitale A, Cucchetti A, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer. 2015;121(22):3998–4006.CrossRefPubMed
12.
Zurück zum Zitat de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Annals of Surgery. 2009;250(3):44–48.PubMed de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Annals of Surgery. 2009;250(3):44–48.PubMed
13.
Zurück zum Zitat Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Annals of Surgical Oncology. 2015;22(12):4020–28.CrossRefPubMed Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Annals of Surgical Oncology. 2015;22(12):4020–28.CrossRefPubMed
14.
Zurück zum Zitat Spolverato G, Kim Y, Alexandrescu S, et al. Is hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaboration. Annals of Surgical Oncology. 2015;22(7):2218–25.CrossRefPubMed Spolverato G, Kim Y, Alexandrescu S, et al. Is hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaboration. Annals of Surgical Oncology. 2015;22(7):2218–25.CrossRefPubMed
15.
Zurück zum Zitat DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Annals of Surgery. 2007;245(5):755–62.CrossRefPubMedPubMedCentral DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Annals of Surgery. 2007;245(5):755–62.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of Surgery. 2008;248(1):84–96.CrossRefPubMed Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of Surgery. 2008;248(1):84–96.CrossRefPubMed
17.
Zurück zum Zitat Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World Journal of Surgery. 2008;32(12):2675–80.CrossRefPubMed Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World Journal of Surgery. 2008;32(12):2675–80.CrossRefPubMed
18.
Zurück zum Zitat Bagante F, Gani F, Spolverato G, et al. Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. Journal of the American College of Surgeons. 2015;221(6):1031–40.CrossRefPubMed Bagante F, Gani F, Spolverato G, et al. Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. Journal of the American College of Surgeons. 2015;221(6):1031–40.CrossRefPubMed
19.
Zurück zum Zitat Hatzaras I, Schmidt C, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Elevated CA 19–9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford). 2010;12(2):134–38.CrossRefPubMedPubMedCentral Hatzaras I, Schmidt C, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Elevated CA 19–9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford). 2010;12(2):134–38.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. Journal of Hepato-Biliary-Pancreatic Surgery. 2003;10(4):288–91.CrossRefPubMed Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. Journal of Hepato-Biliary-Pancreatic Surgery. 2003;10(4):288–91.CrossRefPubMed
21.
Zurück zum Zitat Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World Journal of Surgery. 2007;31(10):2016–22.CrossRefPubMed Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World Journal of Surgery. 2007;31(10):2016–22.CrossRefPubMed
22.
Zurück zum Zitat Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. The British Journal of Surgery. 2002;89(12):1525–31.CrossRefPubMed Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. The British Journal of Surgery. 2002;89(12):1525–31.CrossRefPubMed
23.
Zurück zum Zitat Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? Journal of Surgical Oncology. 1998;69(3):162–67.CrossRefPubMed Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? Journal of Surgical Oncology. 1998;69(3):162–67.CrossRefPubMed
24.
Zurück zum Zitat Amin MB EiC, American Joint Committee on Cancer. Springer, New York; 2017. Amin MB EiC, American Joint Committee on Cancer. Springer, New York; 2017.
25.
Zurück zum Zitat Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Statistics in Medicine. 2007;26(4):734–53.CrossRefPubMed Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Statistics in Medicine. 2007;26(4):734–53.CrossRefPubMed
26.
Zurück zum Zitat Hyder O, Marques H, Pulitano C, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surgery. 2014;149(5):432–38.CrossRefPubMed Hyder O, Marques H, Pulitano C, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surgery. 2014;149(5):432–38.CrossRefPubMed
27.
Zurück zum Zitat Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2013;17(11):1917–28.CrossRefPubMed Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2013;17(11):1917–28.CrossRefPubMed
28.
Zurück zum Zitat Guglielmi A, Ruzzenente A, Campagnaro T, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World Journal of Surgery. 2009;33(6):1247–54.CrossRefPubMed Guglielmi A, Ruzzenente A, Campagnaro T, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World Journal of Surgery. 2009;33(6):1247–54.CrossRefPubMed
29.
Zurück zum Zitat Spolverato G, Bagante F, Weiss, M, Alexandrescu S, Marques HP, Aldrighetti L, et al. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology. Spolverato G, Bagante F, Weiss, M, Alexandrescu S, Marques HP, Aldrighetti L, et al. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology.
Metadaten
Titel
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma
verfasst von
Fabio Bagante, MD
Gaya Spolverato, MD
Matthew Weiss, MD
Sorin Alexandrescu, MD
Hugo P. Marques, MD
Luca Aldrighetti, MD
Shishir K. Maithel, MD
Carlo Pulitano, MD
Todd W. Bauer, MD
Feng Shen, MD
George A. Poultsides, MD
Oliver Soubrane, MD
Guillaume Martel, MD
B. Groot Koerkamp, MD
Alfredo Guglielmi, MD
Endo Itaru, MD
Timothy M. Pawlik, MD, MPH, PhD
Publikationsdatum
02.05.2017
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5870-y

Weitere Artikel der Ausgabe 9/2017

Annals of Surgical Oncology 9/2017 Zur Ausgabe

Health Services Research and Global Oncology

Global Forum of Cancer Surgeons: Declaration of Intent

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.